News

2025.03.26
Genomtec implements changes in organizational structure to accelerate M&A process

2025.03.12
The company will obtain approximately PLN 11 million from the issue to support the commercialization of projects

2025.02.12
Genomtec to issue shares to raise funds to support commercialization of projects

2025.01.28
Genomtec has filed a second patent application for the OncoSNAAT oncology project

2024.06.25
Webinar: Trends in the M&A Market Specific to In-Vitro Diagnostics | 27 June, 2024, 3:00 p.m. (CEST)

Archive

2022.01.20

European Patent Office grants Genomtec with new Patent

Genomtec has received a patent from the European Patent Organization (EPO) for the Genomtec®ID technology and device invented by Genomtec SA.  ...
Read
2022.01.12

Genomtec begins pilot production of Genomtec®ID analyzers

Genomtec has conducted an analysis of its rapid genetic tests that confirmed their effectiveness in detecting all known variants of the ...
Read
2021.12.31

Change of address of Genomtec office in Wroclaw

Genomtec has conducted an analysis of its rapid genetic tests that confirmed their effectiveness in detecting all known variants of the ...
Read
2021.11.30

Genomtec’s laboratory genetic test detects all variants of SARS-CoV-2 including Omicron

Genomtec has conducted an analysis of its rapid genetic tests that confirmed their effectiveness in detecting all known variants of the ...
Read
2021.11.29

Genomtec files a new patent application in the UK

Genomtec has filed a patent application entitled “Thermal interface arrangement” for a proprietary method of heat transfer and ...
Read
2021.11.25

Miron Tokarski Awarded with Laureate of “Leaders of the Future” Ranking by Forbes

Miron Tokarski, co-founder and CEO of Genomtec, found himself among the honourable laureates of the Forbes Magazine ranking: “Leaders of ...
Read

Archive